Screener
Exelixis EXEL Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Exelixis’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0000939767-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 650,472 | 683,104 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000 shares authorized and no shares issued | — | — |
| Common stock, $0.001 par value; 400,000 shares authorized; issued and outstanding: 248,885 and 262,483 at June 30, 2026, and December 31, 2025, respectively | 249 | 262 |
| Additional paid-in-capital | 2,108,059 | 2,234,411 |
| Accumulated other comprehensive income (loss) | (2,013) | 3,476 |
| Accumulated deficit | (262,533) | (76,830) |
Item 1. Financial Statements.
FAQ
- What is Exelixis's preferred stock, shares authorized?
- Exelixis (EXEL) reported preferred stock, shares authorized of $10M in Q2 2026.
- How has Exelixis's preferred stock, shares authorized changed year-over-year?
- Exelixis's preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Exelixis's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Exelixis's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.
- What does preferred stock, shares authorized mean?
- Preferred Stock, Shares Authorized
Ask your AI about Exelixis's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude